NEW YORK – May 6, 2024 – Research to Prevent Blindness (RPB) is pleased to announce that it has opened a new round of grant funding for high-impact vision research. With a focus on scientific excellence, RPB funds research across all sight-threatening conditions, including glaucoma, age-related macular degeneration, inherited retinal diseases, amblyopia, low vision and many more. In this award cycle (one of two award cycles per year), RPB is offering a variety of grants for individual researchers, as well as Unrestricted Grants and Challenge Grants to high-performing departments of ophthalmology. RPB provides a total of approximately $11 million in grant funding annually.
All award applications for this funding cycle are due July 1, 2024, with nomination forms due no later than June 15.
“We’re thrilled to offer these prestigious vision research awards that will help to move the needle in terms of supporting the development of treatments, preventives and cures for all conditions that damage and destroy sight,” said Brian F. Hofland, PhD, President of Research to Prevent Blindness. “We recognize that research is a ‘long game’ and it is only through continued, sustained investment that we will continue to make the kind of game-changing progress that we’ve made over the past 64 years.”
The list of individual researcher grants that are currently open is listed below.
RPB Career Development Award
The RPB Career Development Award helps RPB-supported ophthalmology chairs support promising early-career ophthalmology faculty who have demonstrated their potential for independent research (but have not yet received an NIH R01 or equivalent award) with significant research projects. The $350,000 grant is payable for up to four years.
There are two types of CDAs available in this award cycle:
RPB Career Advancement Award
The RPB Career Advancement Award (CAA) assists outstanding early-career vision scientists in pursuit of ongoing research of unusual significance and promise. This one-time award of $150,000 is available to candidates who have already received their first NIH R01 and are collecting new data to apply for a second R01. This award is open to researchers at any institution of higher education in the U.S.
There are two types of CAAs available in this award cycle:
RPB Physician-Scientist Award
Recognizing the unique contributions of clinician-scientists and their deep commitment to patient care, the RPB Physician-Scientist Award promotes the clinical and/or basic science research of clinicians. This $300,000 award is open to MDs or MD/PhDs at RPB-supported departments of ophthalmology.
There are three types of Physician-Scientist Awards available in this award cycle:
RPB Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration
The RPB Catalyst Awards will provide funds to researchers who are working on novel approaches to understanding or treating age-related macular degeneration (AMD). RPB is partnering with:
to co-fund up to three Catalyst Awards (one award with each partner) in the amount of $300,000 each. Translational projects – clinically relevant research that could lead to therapeutics or treatment for AMD that is not yet in clinical trials – are encouraged. This award is open to researchers at any institution of higher education in the U.S.
RPB International Research Collaborators Award
The RPB International Research Collaborators Award promotes international collaborations through which researchers in the U.S. and outside the U.S. gain new knowledge and skills. Under a reciprocal arrangement, supported by this $75,000 grant, a U.S.-based researcher or team will be funded to go for a period of time to an institution outside the U.S. to deepen collaborative relationships with researchers there. In turn, the institution outside the U.S. will send a researcher or team members for a period of time to the U.S. institution. This award is open to researchers at any institution of higher education in the U.S.
RPB Stein Innovation Award – Outside Ophthalmology
The RPB Stein Innovation Award provides $300,000 to two groups of researchers (those inside ophthalmology departments and those outside ophthalmology departments), both with a common goal of understanding the visual system and the diseases that compromise its function. During this award cycle, RPB is accepting applications from researchers outside ophthalmology departments. These awards are intended to provide seed money to proposed high-risk / high-gain vision research that is innovative and cutting-edge. This award is open to researchers at any institution of higher education in the U.S.
RPB Medical Student Eye Research Fellowship
The RPB Medical Student Eye Research Fellowship allows gifted students to take a year off from allopathic or osteopathic medical school and devote time to the pursuit of a research project within an RPB-supported department of ophthalmology. RPB encourages medical students who are under-represented in medicine and women to apply to these awards to help bring needed diversity to the field of ophthalmology.
Three types of Medical Student Eye Research Fellowships are available in this award cycle:
To review more information on any of these grants, including eligibility criteria and application guidelines, please visit the RPB website https://bit.ly/RPBgrants2024.
If you have questions regarding the RPB Grants Program, please contact a member of RPB's Grants Administration team, MariaClaudia Lora-Montano (646-892-9564; mlora@rpbusa.org) or Pattie Moran (646-892-9566; pmoran@rpbusa.org).
###
About Research to Prevent Blindness
Research to Prevent Blindness (RPB) is the leading nonprofit organization supporting eye research directed at the prevention, treatment or eradication of all diseases that damage and destroy sight. As part of this purview, RPB also supports efforts to grow and sustain a robust and diverse vision research community. Since it was founded in 1960 by Dr. Jules Stein, RPB has awarded more than $413 million in research grants to the most talented vision scientists at the nation’s leading medical schools. As a result, RPB has been associated with nearly every major breakthrough in the understanding and treatment of vision loss in the past 64 years. Learn more at www.rpbusa.org.
May 6, 2024
The existence of the National Eye Institute, the most important source of funding for vision research in the U.S., is being threatened.
The ARPA-H THEA project takes on an exciting challenge.
Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |